Busey Bank - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 991 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Busey Bank ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$224,628
-0.3%
5,952
+20.3%
0.01%
+11.1%
Q2 2023$225,340
-26.4%
4,946
-34.5%
0.01%
-30.8%
Q1 2023$306,106
-26.3%
7,547
-7.4%
0.01%
-31.6%
Q4 2022$415,252
-5.4%
8,1470.0%0.02%
-13.6%
Q3 2022$439,000
-32.7%
8,147
-19.7%
0.02%
-26.7%
Q2 2022$652,000
-17.8%
10,147
-0.7%
0.03%
-6.2%
Q1 2022$793,000
-10.0%
10,218
-0.5%
0.03%
-3.0%
Q4 2021$881,000
+6.4%
10,267
-0.3%
0.03%0.0%
Q3 2021$828,000
+227.3%
10,295
+227.6%
0.03%
+175.0%
Q2 2021$253,000
-4.5%
3,1430.0%0.01%
-7.7%
Q1 2021$265,000
+10.0%
3,143
+4.8%
0.01%
-7.1%
Q4 2020$241,0000.0%3,0000.0%0.01%
-6.7%
Q3 2020$241,000
-6.6%
3,0000.0%0.02%
-16.7%
Q2 2020$258,000
+5.7%
3,0000.0%0.02%
-10.0%
Q1 2020$244,000
-2.8%
3,0000.0%0.02%
+25.0%
Q4 2019$251,000
-6.0%
3,000
-1.6%
0.02%
-15.8%
Q3 2019$267,000
+6.8%
3,0500.0%0.02%
-20.8%
Q2 2019$250,000
+0.8%
3,0500.0%0.02%
+4.3%
Q1 2019$248,000
+23.4%
3,0500.0%0.02%
+9.5%
Q4 2018$201,000
-15.9%
3,050
-1.6%
0.02%
-4.5%
Q3 2018$239,000
+2.6%
3,100
-1.7%
0.02%
-4.3%
Q2 2018$233,000
+15.3%
3,155
+1.8%
0.02%
+9.5%
Q1 2018$202,000
-49.0%
3,100
-45.6%
0.02%
-65.6%
Q4 2013$396,000
+7.9%
5,700
+1.8%
0.06%
+1.7%
Q3 2013$367,000
-5.4%
5,6000.0%0.06%
-7.7%
Q2 2013$388,0005,6000.06%
Other shareholders
BAXTER INTL INC shareholders Q3 2022
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders